Clinical Trials Directory

Trials / Completed

CompletedNCT05286021

Comparison of the Clinical Performance and Safety of the Ambu®AuraGainTM Laryngeal Mask in Children Undergoing Surgery in the Supine and Prone Position - A Prospective, Noninferiority Clinical Trial

Status
Completed
Phase
Study type
Observational
Enrollment
126 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
2 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The Ambu Auragain is a 2nd generation laryngeal mask airway that is widely used in adult and pedicatric patients. While its use is generally recommended in patients undergoing surgery in the supine position, depending on patient characteristics, type of surgery and experience of the anesthesiologist, it may also be used in the lateral or prone position. There have been reports of LMA use in patients undergoing short procedures in the prone position, but its safety in pediatric patients is not clear. This study was designed to compare oropharyngeal leak pressure between children undergoing surgery in the supine and prone position using the Ambu Auragain LMA.

Conditions

Timeline

Start date
2022-01-05
Primary completion
2024-01-27
Completion
2024-01-27
First posted
2022-03-18
Last updated
2024-06-06

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05286021. Inclusion in this directory is not an endorsement.